Last updated on March 2018

A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia (NAVIGATE-AD)

Brief description of study

The main purpose of this study is to evaluate the safety and the effect on brain tau of the study drug LY3202626 in participants with mild Alzheimer's disease (AD) dementia.

Clinical Study Identifier: TX198911

Find a site near you

Start Over

Meridien Research - Spring Hill

120 Medical Boulevard, #103 Spring Hill, FL USA
  Connect »